Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia

KORKMAZ EKREN, PERVİN; Toreyin, Zehra; Berk Takir, Huriye; Kalamanoglu Balci, Merih; GAYGISIZ, ÜMMÜGÜLSÜM; GÜRSEL, GÜL; ERGAN, BEGÜM; Yalcin, Aslihan; Salturk, Cuneyt; AYDOĞDU, MÜGE; Ergun, Recai; Guven, Pinar; Ulubay, Gaye; Gurun Kaya, Aslihan; ÇELTİK, AYGÜL; ULUER, HATİCE; Bacakoglu, Feza; SAYINER, ABDULLAH

doi:10.5578/tt.59748

Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia

KORKMAZ EKREN P., Toreyin Z. N., Berk Takir H., Kalamanoglu Balci M., GAYGISIZ Ü., GÜRSEL G., ...Daha Fazla

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.65, sa.4, ss.271-281, 2017 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 65 Sayı: 4
Basım Tarihi: 2017
Doi Numarası: 10.5578/tt.59748
Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.271-281
Anahtar Kelimeler: Nosocomial infection, pneumonia, multidrug resistant, colistimethate sodium, toxicity
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Introduction: Colistimethate sodium (CMS) is frequently used in the treatment of nosocomial multidrug-resistant gram-negative infections. Nephrotoxicity is the most important side effect. The aim of this study is to evaluate the effect of colistin on nephrotoxicity and to assess prognosis in patients treated with CMS due to hospital-acquired pneumonia (HAP).